1 |
王明镜, 胡晓梅, 邓中阳, 等. 免疫性血小板减少症的免疫机制研究进展[J]. 临床血液学杂志, 2017, 30(5): 725-728.
|
2 |
中华医学会血液学分会血栓与止血学组. 成人原发免疫性血小板减少症诊断与治疗中国专家共识(2012年版) [J]. 中华血液学杂志, 2012, 33(11): 975-977.
|
3 |
张阵, 陈兰举. 特发性血小板减少性紫癜免疫机制研究进展 [J]. 中华全科医学, 2011, 9(9): 1438-1440.
|
4 |
徐维家, 李志, 杨婷婷, 等. 特发性血小板减少性紫癜患者Th1、Th17和Treg细胞及其细胞因子检测及临床意义 [J]. 国际检验医学杂志, 2013, 34(14): 1792-1793, 1795.
|
5 |
Takahashi N, Saitoh T, Gotoh N, et al. The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP [J]. BMC Immunol, 2017, 18(1): 18-26.
|
6 |
郭新红, 赵芳, 石伟, 等. 特发性血小板减少性紫癜患者Th1/Th2的细胞因子水平及临床意义 [J]. 细胞与分子免疫学杂志, 2012, 28(11): 1185-1187.
|
7 |
阮毅燕, 陈瑜毅, 唐文珏, 等. 特发性血小板减少性紫癜患儿细胞免疫功能变化及临床意义 [J]. 医学研究杂志, 2017, 46(2): 43-45.
|
8 |
Li J, Wang Z, Hu X, et al. Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura [J]. Immunol Lett, 2013, 154(1-2): 42-48.
|
9 |
Yu S, Liu C, Li L, et al. Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia [J]. Lab Invest, 2015, 95(2): 157-167.
|
10 |
王颖超, 刘满菊, 朱桂英, 等. Th17/Treg细胞比例失衡在儿童原发性免疫性血小板减少症中的意义 [J]. 中国当代儿科杂志, 2016, 18(3): 238-242.
|
11 |
Henriques A, Inês L, Pais ML, et al. Th17 cells in systemic lupus erythematosus share functional features with Th17 cells from normal bone marrow and peripheral tissues [J]. Clin Rheumatol, 2012, 31(3): 483-491.
|
12 |
Adams G, Graebner L, Sayed A, et al. Cytokine fluctuations in immune thrombocytopenia (ITP) over time; insights into the pathogenesis and evolution of the disease [J]. Blood, 2016, 128(22): 2549-2551.
|
13 |
Blair PA, Norena LY, Flores-Borja F, et al. CD19(+)CD24(hi)CD38(hi)B Cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus Erythematosus patients [J]. Immunity, 2010, 32(1): 129-140.
|
14 |
李鑫, 王芳, 丁凯阳, 等. 调节性B细胞在免疫性血小板减少症发病过程中的意义 [J]. 中国实验血液学杂志, 2014, 22(2): 403-406.
|
15 |
Mauri C, Bosma A. Immune regulatory function of B cells [J]. Annu Rev Immunol, 2012, 30(12): 221-241.
|
16 |
Flores-Borja F,Bosma A,Ng D,et al. CD19(+)CD24(hi)CD38(hi)B cells maintain regulatory T cells while limiting Th1 and Th17 differentiation [J]. Sci Transl Med, 2013, 5(173): 173-196.
|
17 |
Tang Y, Qu W, Wang Y, et al. Quantity and function of regulatory B cells of the patients with immune thrombocytopenia [J]. Zhonghua Yi Xue Za Zhi, 2015, 95(20): 1599-1601.
|
18 |
Wu CL, Wang Q, Zheng L, et al. Correlation of Breg with CD4(+)T cells of peripheralblood in patients with CITP and its clinical significance [J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2013, 21(6): 1517-1521.
|
19 |
Qu W, Tang YJ, Shao ZH. Regulatory B Cells Decreased in Patients with Immune Thrombocytopenia [J]. Blood, 2015, 126(23): 4627-4628.
|
20 |
Semple JW. Bregging rights in ITP [J]. Blood, 2012, 120(16): 3169-3170.
|